furosemide has been researched along with Hepatocellular Carcinoma in 5 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coexistent hepatocellular carcinoma (HCC) was the only significant predictive variable that attenuated the efficacy of TLV." | 5.46 | Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. ( Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M, 2017) |
| "A case of hyperreninemic hypoaldosteronism secondary to metastatic hepatocellular carcinoma is reported." | 2.38 | Hyperreninemic hypoaldosteronism due to hepatocellular carcinoma metastatic to the adrenal gland. ( Asano, Y; Ido, K; Kawamoto, C; Kimura, K; Muto, S; Ohtani, M; Otabe, S; Sato, K, 1991) |
| "Coexistent hepatocellular carcinoma (HCC) was the only significant predictive variable that attenuated the efficacy of TLV." | 1.46 | Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. ( Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M, 2017) |
| "Cirrhotic patients with hepatocellular carcinoma (HCC) frequently develop hepatic encephalopathy." | 1.34 | Hypercalcemic encephalopathy in a patient with hepatocellular carcinoma. ( Domènech, E; Mòdol, JM; Soldevila, B; Tudela, P, 2007) |
| "Amiodarone and EMD 21388 were without effect both in cytosol and nuclear extract." | 1.29 | Drug competition for intracellular triiodothyronine-binding sites. ( Barlow, JW; Curtis, AJ; Loidl, NM; Raggatt, LE; Stockigt, JR; Topliss, DJ, 1994) |
| "Cells from a rat hepatoma grown in culture were found to activate methyldopa to intermediates which are bound irreversibly to cellular proteins." | 1.26 | Methyldopa binding to cells in culture. ( Dybing, E, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, M | 1 |
| Yada, M | 1 |
| Tanaka, K | 1 |
| Senjyu, T | 1 |
| Goya, T | 1 |
| Motomura, K | 1 |
| Kohjima, M | 1 |
| Kato, M | 1 |
| Masumoto, A | 1 |
| Kotoh, K | 1 |
| Tudela, P | 1 |
| Soldevila, B | 1 |
| Mòdol, JM | 1 |
| Domènech, E | 1 |
| Barlow, JW | 1 |
| Curtis, AJ | 1 |
| Raggatt, LE | 1 |
| Loidl, NM | 1 |
| Topliss, DJ | 1 |
| Stockigt, JR | 1 |
| Dybing, E | 1 |
| Otabe, S | 1 |
| Muto, S | 1 |
| Asano, Y | 1 |
| Sato, K | 1 |
| Ohtani, M | 1 |
| Kawamoto, C | 1 |
| Ido, K | 1 |
| Kimura, K | 1 |
1 review available for furosemide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Hyperreninemic hypoaldosteronism due to hepatocellular carcinoma metastatic to the adrenal gland.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Carcinoma, Hepato | 1991 |
4 other studies available for furosemide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weig | 2017 |
Hypercalcemic encephalopathy in a patient with hepatocellular carcinoma.
Topics: Aged; Brain Diseases, Metabolic; Calcium; Carcinoma, Hepatocellular; Diagnosis, Differential; Diuret | 2007 |
Drug competition for intracellular triiodothyronine-binding sites.
Topics: Amiodarone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Binding, Competitive; C | 1994 |
Methyldopa binding to cells in culture.
Topics: Acetaminophen; Allopurinol; Animals; Ascorbic Acid; Carcinoma, Hepatocellular; Cells, Cultured; Defe | 1977 |